Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41‐2272 and BAY 60‐2770 alone or in combination with a phosphodiesterase type 5 inhibitor

Publisher： John Wiley & Sons Inc

E-ISSN： 1520-6777|34|8|787-793

ISSN： 0733-2467

Source： NEUROUROLOGY AND URODYNAMICS, Vol.34, Iss.8, 2015-11, pp. : 787-793

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological characterisation of the relaxation induced by the soluble guanylate cyclase activator, BAY 60‐2770 in rabbit corpus cavernosum

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 657-664

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relaxation Effect of Phosphodiesterase-5 Inhibitor on the Animal Bladder and Prostatic Urethra: in vitro and in vivo Study

By  

Urologia Internationalis, Vol. 84, Iss. 2, 2010-03 ,pp. : 231-235

Karger

Access to resources Recommend Favorite

Alpha1‐adrenergic receptors mediate bladder overactivity induced by cold stress in rats with bladder outlet obstruction

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 34, Iss. 3, 2015-03 ,pp. : 280-285

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction

By Axilrod Andrew C.  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3189-3198

Informa Healthcare

Access to resources Recommend Favorite

Daily phosphodiesterase type 5 inhibitor therapy: a new treatment option for prostatitis/prostatodynia?

By  

TRENDS IN UROLOGY AND MEN'S HEALTH, Vol. 6, Iss. 3, 2015-03 ,pp. : 40-41

John Wiley & Sons Inc

Access to resources Recommend Favorite